Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 543
Selected: 0
NCT IDTitle
NCT06540950Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer
NCT06136026Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer
NCT03009253Translational Research on Locally Advanced Pancreatic Adenocarcinoma
NCT07027605Multi-Reader Multi-Case Trial Evaluating Computer-Aided Tool for Prognostic Prediction of Colorectal Liver Metastases
NCT07338396A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer Patients
NCT07019337Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer
NCT05540145Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER2-negative MMR-proficient Locally Advanced Gastric or Gastroesophageal Adenocarcinoma
NCT07383246CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC
NCT05892354Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy
NCT06241079Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma
NCT07590024RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma
NCT03042000Multicenter, Prospective, RCT:Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.
NCT06611657Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases
NCT07307053Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)
NCT07324798Adaptive Radiotherapy for Genitourinary Cancers
NCT05707598Multivisceral Radical Resection for Surgical T4b Colorectal Cancer: Propensity Score-matched Study Comparing the the Laparoscopic and Open Approaches
NCT01745107Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
NCT04835324Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study
NCT05794750Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC(AK104-IIT-13)
NCT06691594Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy
NCT07298239An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT03713372Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma
NCT07029464Comparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right Colon Cancer : A Multicenter Propensity Score Matching Analysis
NCT06048146A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis
NCT07396090Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors
NCT04807673Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)
NCT03291574Perioperative Electroacupuncture for Gastric Cancer Patients After Gastrectomy
NCT07186868QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer
NCT06255197Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
NCT06837597Jianzhong Qushi in Chronic RRI
NCT02858206Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
NCT05524389Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions
NCT05911152Safety and Feasibility of Laparoscopic Intracorporeal Anastomosis for Colorectal Surgery- A Multiple Center Real World Study
NCT07132242SHR-A1811 Combine With Pyrotinib for Locally Advanced/Metastatic HER2 Positive Breast Cancer
NCT06771596Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the Cervix
NCT06156761Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer
NCT07084519Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction
NCT06197581Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer
NCT05050630Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL
NCT06429839Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients
NCT06416930Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma
NCT06513364Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer
NCT03016364Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain
NCT06773507Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors
NCT07440901Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy
NCT05762900Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
NCT07560358Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer
NCT07636824Postoperative Concurrent Chemoradiotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
NCT06577961Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients
NCT05188859First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma